[Study of the antineoplastic effect of lienomycin in animal experiments].
D000284:Administration, Oral; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D002284:Carcinoma, Brown-Pearce / Q000188:drug therapy*; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy*; D003864:Depression, Chemical; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007674:Kidney Diseases / Q000139:chemically induced; D007942:Leukemia, Experimental / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D051379:Mice; D009336:Necrosis / Q000139:chemically induced; D011817:Rabbits; D012510:Sarcoma 180 / Q000188:drug therapy*; D012511:Sarcoma 37 / Q000188:drug therapy*; D013997:Time Factors
D000903:Antibiotics, Antineoplastic
Issledovanie protivoopukholevoĭ aktivnosti lienomitsina v opytakh na zhivotnykh.